Model
Edge
GW Pharmaceuticals PLC
0001351288
Filing Type
8-K
Filing Date
5/4/2021
Updated
5/5/21, 11:23 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events
EX-99.1
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events